Inside Precision Medicine March 5, 2024
Helen Albert

A large study led by Kyung Hee University in Seoul shows that infection with SARS-CoV-2 significantly increases the risk of developing autoimmune inflammatory rheumatic disease for up to a year after infection.

The research, published in the Annals of Internal Medicine, shows that COVID-19 increased the risk for being diagnosed with an autoimmune inflammatory rheumatic disease by 25–30% compared with uninfected people or a group of individuals with previous flu, but not COVID infection.

“Emerging data suggest a higher risk for autoimmune inflammatory rheumatic diseases among patients with a history of COVID-19. However, these findings are based entirely on comparisons between groups infected with SARS-CoV-2 and those that are not, which might be biased by differences in health-seeking behavior and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Patient experience on the upswing, Leapfrog data suggests
Patients' hospital experiences improving after pandemic decline
CDC: Hospitals no longer required to report COVID-19 data
The little nonprofit behind a big Covid theory
Bird flu is spreading in cattle. Here's what we know (and what we don't).

Share This Article